Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 28

Sort by

Sort Order Select

Journal Articles

Bortezomib (BOR)-Thalidomide-Dexamethasone (VTD) and High-Dose Melphalan (HDM) As First Line Treatment for Multiple Myeloma (MM) Is Associated with a Lower Rate of Second Primary Malignancies (SPMs) Compared to TD Plus HDM

Annamaria Brioli, MD, Annalisa Pezzi, Statistician, Daniele Derudas, MD, Maria Concetta Petti, MD, Beatrice Anna Zannetti, MD, Felicetto Ferrara, MD, Serena Rocchi, MD, Francesco Nobile, MD, Anna Baraldi, MD, Pellegrino Musto, MD, Francesco Lanza, MD, Katia Mancuso, MD, Letizia Canepa, MD, Lucio Catalano, MD, Antonio Lazzaro, MD, Graziella Pinotti, MD, Mario Boccadoro, MD, Michele Cavo, MD

Blood (2014) 124 (21): 1182.

https://doi.org/10.1182/blood.V124.21.1182.1182

Published: 2014

Journal Articles

Increased BMI correlates with higher risk of disease relapse and differentiation syndrome in patients with acute promyelocytic leukemia treated with the AIDA protocols

Massimo Breccia, Luca Mazzarella, Vincenzo Bagnardi, Davide Disalvatore, Giuseppina Loglisci, Giuseppe Cimino, Anna Maria Testi, Giuseppe Avvisati, Maria Concetta Petti, Clara Minotti, Roberto Latagliata, Robin Foà, Pier Giuseppe Pelicci, Francesco Lo-Coco

Blood (2012) 119 (1): 49–54.

https://doi.org/10.1182/blood-2011-07-369595

Published: 2012

Journal Articles

Superior Complete Response Rate (CR) and Progression-Free Survival (PFS) with Bortezomib-Thalidomide-Dexamethasone (VTD) Versus Thalidomide-Dexamethasone (TD) As Consolidation Therapy After Autologous Stem-Cell Transplantation (ASCT) in Multiple Myeloma (MM)

Blood (2011) 118 (21): 1871.

https://doi.org/10.1182/blood.V118.21.1871.1871

Published: 2011

Journal Articles

Clinical Follow-up of Patients with Myeloproliferative Neoplasms Presenting Skin Ulcers During Treatment with Hydroxyurea

Blood (2011) 118 (21): 5157.

https://doi.org/10.1182/blood.V118.21.5157.5157

Published: 2011

Journal Articles

Clinical Features of Idiopathic Erythrocytosis Compared to Polycythemia Vera JAK-2 V617F Positive and Negative Patients

Roberto Latagliata, Agostino Tafuri, Antonio Spadea, Antonietta Ferretti, Daniela Diverio, Massimo Breccia, Mariella D'Andrea, Alessandro Andriani, Marco Montanaro, Michele Cedrone, Enrico Montefusco, Angela Rago, M.D., Odoardo Maria Olimpieri, Antonino Bagnato, MD, Francesca Biondo, Federico Vozella, Maria Cantonetti, MD, Maria Concetta Petti, MD, Giuliana Alimena

Blood (2011) 118 (21): 5172.

https://doi.org/10.1182/blood.V118.21.5172.5172

Published: 2011

Journal Articles

Increased Body Mass Index Correlates with Higher Risk of Disease Relapse and Differentiation Syndrome in Patients with Acute Promyelocytic Leukemia Treated with Aida Protocols

Massimo Breccia, MD, Luca Mazzarella, MD, Giuseppina Loglisci, Vincenzo Bagnardi, Davide Disalvatore, Roberto Latagliata, Anna Maria Testi, Giuseppe Cimino, MD, Giuseppe Avvisati, MD, Maria Concetta Petti, Pier Guiseppe Pelicci, Robin Foá, MD, Francesco Lo Coco

Blood (2011) 118 (21): 4866.

https://doi.org/10.1182/blood.V118.21.4866.4866

Published: 2011

Journal Articles

AIDA 0493 protocol for newly diagnosed acute promyelocytic leukemia: very long-term results and role of maintenance

Blood (2011) 117 (18): 4716–4725.

https://doi.org/10.1182/blood-2010-08-302950

Published: 2011

Includes: Supplemental data

Journal Articles

Hepatitis B Virus (HBV) Reactivation In Anti-HB Core Antigen (anti-HBc) Positive Patients with Hematological Malignancies: A Prospective Multicenter Study

Blood (2010) 116 (21): 4911.

https://doi.org/10.1182/blood.V116.21.4911.4911

Published: 2010

Journal Articles

A Phase II Trial of Rituximab-CHOP Chemotherapy Followed by Yttrium 90 ( 90 Y) Ibritumomab Tiuxetan ( 90 Y-IT) for Previously Untreated Elderly Diffuse Large B-Cell Lymphoma (DLBCL) Patients.

Pier Luigi Zinzani, Mariapaola Fina, Monica Tani, Vittorio Stefoni, Letizia Gandolfi, Alessandro Broccoli, Cinzia Pellegrini, Enrico Derenzini, Giuseppe Rossi, MD, Emanuele Angelucci, Gianluca Gaidano, Maria Concetta Petti, Maurizio Martelli, Umberto Vitolo, Stefano Fanti, Michele Baccarani

Blood (2009) 114 (22): 2720.

https://doi.org/10.1182/blood.V114.22.2720.2720

Published: 2009

Journal Articles

Clinical Results in Patients with Primary and Secondary Myelofibrosis Treated with Monthly Cycles of Oral Melphalan.

Ida Carmosino, Roberto Latagliata, MD, Massimo Breccia, Laura Cannella, Federico Vozella, Paola Volpicelli, Michelina Santopietro, Antonio Spadea, MD, PhD, Maria Concetta Petti, Giuliana Alimena

Blood (2009) 114 (22): 4985.

https://doi.org/10.1182/blood.V114.22.4985.4985

Published: 2009

Journal Articles

“An Intention-to-Treat Analysis of Rome Transplant Network Policy for Alternative Donor Search in Patients Lacking a HLA Matched Related donor”.

Blood (2009) 114 (22): 1195.

https://doi.org/10.1182/blood.V114.22.1195.1195

Published: 2009

Journal Articles

A Phase III Study of Enoxaparin Versus Low-Dose Warfarin Versus Aspirin as Thromboprophylaxis for Patients with Newly Diagnosed Multiple Myeloma Treated up-Front with Thalidomide-Containing Regimens

Blood (2008) 112 (11): 3017.

https://doi.org/10.1182/blood.V112.11.3017.3017

Published: 2008

Journal Articles

Treatment with Imatinib in Very Elderly (> 75 Years) CML Patients.

Roberto Latagli Ata, Massimo Breccia, Simona Sica, Antonio Spadea, MD, PhD, Ada D’Addosio, Ida Carmosino, Silvia De Matteis, Caterina Stefanizzi, Paola Volpicelli, Laura Napoleone, Federico Vozella, Maria Concetta Petti, Giuliana Alimena

Blood (2008) 112 (11): 1096.

https://doi.org/10.1182/blood.V112.11.1096.1096

Published: 2008

Journal Articles

Efficacy and Safety of FCR (Fludarabine, Cyclophosphamide, Rituximab) Followed by Yttrium-90 Ibritumomab Tiuxetan in Relapsed Follicular Lymphoma (FL) Patients

Francesco Pisani, Carlo Ludovico Maini, Rosa Sciuto, Laura Dessanti, Antonio Spadea, Andrea Mengarelli, Mariella D’Andrea, Sandra Rea, Luisa Romano, Maria Concetta Petti

Blood (2008) 112 (11): 5003.

https://doi.org/10.1182/blood.V112.11.5003.5003

Published: 2008

Journal Articles

5-Azacytidine, Valproic Acid and ALL-Trans Retinoic Acid in INT-2/High Risk Myelodysplastic Syndromes: Results of the GIMEMA MDS0205 Multicenter Trial

Maria Teresa Voso, Valeria Santini, Carlo Finelli, Lorenza Borin, Emanuele Angelucci, Giuseppe Fioritoni, Benedetta Neri, Agostino Cortellezi, Oreste Villani, Francesco Buccisano, Giovanni Martinelli, Maria Concetta Petti, Gina Zini, Alfonso Piciocchi, Paola Fazi, Giuliana Alimena, Marco Gobbi, Vincenzo Liso, Giuseppe Leone

Blood (2008) 112 (11): 3648.

https://doi.org/10.1182/blood.V112.11.3648.3648

Published: 2008

Journal Articles

Standard Versus High Dose Lenograstim in Adults with Hematological Malignancies for Peripheral Blood Progenitor Cell Mobilization: Results of a Retrospective Study on Behalf of Rome Transplant Network.

Azzurra Anna Romeo, Anna Chierichini, Diana Giannarelli, Alessandra Spagnoli, Barbara Anaclerico, Mariangela Vittori, Michele Vacca, Maria Gozzer, Antonio Spadea, MD, PhD, Luciana Annino, Maria Concetta Petti, Andrea Mengarelli, William Arcese, MD

Blood (2008) 112 (11): 2302.

https://doi.org/10.1182/blood.V112.11.2302.2302

Published: 2008

Journal Articles

Rituximab + IEV/MINE Second Line Approach in Relapsed/Refractory Non Hodgkin Lymphoma (NHL): Efficacy and Safety

Velia Bongarzoni, MD, Barbara Anaclerico, MD, Paola Anticoli Borza, MD, Michele Cedrone, MD, Anna Chierichini, MD, Susanna Fenu, MD, Benedetto Ronci, MD, Mariangela Vittori, Maria Cantonetti, MD, Maria Concetta Petti, MD, Luciana Annino, MD

Blood (2008) 112 (11): 4954.

https://doi.org/10.1182/blood.V112.11.4954.4954

Published: 2008

Journal Articles

Decisional Flow with a Score System To Start Platelet-Lowering Treatment in Patients with Essential Thrombocythemia (ET): Long-Term Results.

Roberto Latagliata, MD, Angela Rago, MD, Antonio Spadea, MD, Cristina Santoro, MD, Ida Carmosino, MD, Massimo Breccia, MD, Laura Napoleone, MD, Angelo Fama, MD, Francesca Biondo, MD, Paola Volpicelli, MD, Maria Concetta Petti, PhD, Giuliana Alimena, PhD, Maria Gabriella Mazzucconi, PhD

Blood (2007) 110 (11): 4636.

https://doi.org/10.1182/blood.V110.11.4636.4636

Published: 2007

Journal Articles

Increased Risk of Thrombotic Events in Patients with Acute Promyelocytic Leukemia (APL) Receiving ATRA Treatment: Does It Correlate with CD2 and FLT3 Expression?.

Massimo Breccia, MD, Roberto Latagliata, MD, Ida Carmosino, MD, Eleonora Russo, MD, Mariella D’Andrea, MD, Erica Finolezzi, MD, Nicol Iorio, MD, Cinzia Fazio, MD, Giuseppe Avvisati, PhD, Maria Concetta Petti, PhD, Francesco Lo-Coco, PhD, Franco Mandelli, PhD

Blood (2005) 106 (11): 887.

https://doi.org/10.1182/blood.V106.11.887.887

Published: 2005

Journal Articles

Oral Melphalan, Prednisone and Thalidomide for Multiple Myeloma.

Blood (2005) 106 (11): 779.

https://doi.org/10.1182/blood.V106.11.779.779

Published: 2005

NARROW

Bortezomib (BOR)-Thalidomide-Dexamethasone (VTD) and High-Dose Melphalan (HDM) As First Line Treatment for Multiple Myeloma (MM) Is Associated with a Lower Rate of Second Primary Malignancies (SPMs) Compared to TD Plus HDM

Increased BMI correlates with higher risk of disease relapse and differentiation syndrome in patients with acute promyelocytic leukemia treated with the AIDA protocols

Superior Complete Response Rate (CR) and Progression-Free Survival (PFS) with Bortezomib-Thalidomide-Dexamethasone (VTD) Versus Thalidomide-Dexamethasone (TD) As Consolidation Therapy After Autologous Stem-Cell Transplantation (ASCT) in Multiple Myeloma (MM)

Clinical Follow-up of Patients with Myeloproliferative Neoplasms Presenting Skin Ulcers During Treatment with Hydroxyurea

Clinical Features of Idiopathic Erythrocytosis Compared to Polycythemia Vera JAK-2 V617F Positive and Negative Patients

Increased Body Mass Index Correlates with Higher Risk of Disease Relapse and Differentiation Syndrome in Patients with Acute Promyelocytic Leukemia Treated with Aida Protocols

AIDA 0493 protocol for newly diagnosed acute promyelocytic leukemia: very long-term results and role of maintenance

Hepatitis B Virus (HBV) Reactivation In Anti-HB Core Antigen (anti-HBc) Positive Patients with Hematological Malignancies: A Prospective Multicenter Study

A Phase II Trial of Rituximab-CHOP Chemotherapy Followed by Yttrium 90 ( 90 Y) Ibritumomab Tiuxetan ( 90 Y-IT) for Previously Untreated Elderly Diffuse Large B-Cell Lymphoma (DLBCL) Patients.

Clinical Results in Patients with Primary and Secondary Myelofibrosis Treated with Monthly Cycles of Oral Melphalan.

“An Intention-to-Treat Analysis of Rome Transplant Network Policy for Alternative Donor Search in Patients Lacking a HLA Matched Related donor”.

A Phase III Study of Enoxaparin Versus Low-Dose Warfarin Versus Aspirin as Thromboprophylaxis for Patients with Newly Diagnosed Multiple Myeloma Treated up-Front with Thalidomide-Containing Regimens

Treatment with Imatinib in Very Elderly (> 75 Years) CML Patients.

Efficacy and Safety of FCR (Fludarabine, Cyclophosphamide, Rituximab) Followed by Yttrium-90 Ibritumomab Tiuxetan in Relapsed Follicular Lymphoma (FL) Patients

5-Azacytidine, Valproic Acid and ALL-Trans Retinoic Acid in INT-2/High Risk Myelodysplastic Syndromes: Results of the GIMEMA MDS0205 Multicenter Trial

Standard Versus High Dose Lenograstim in Adults with Hematological Malignancies for Peripheral Blood Progenitor Cell Mobilization: Results of a Retrospective Study on Behalf of Rome Transplant Network.

Rituximab + IEV/MINE Second Line Approach in Relapsed/Refractory Non Hodgkin Lymphoma (NHL): Efficacy and Safety

Decisional Flow with a Score System To Start Platelet-Lowering Treatment in Patients with Essential Thrombocythemia (ET): Long-Term Results.

Increased Risk of Thrombotic Events in Patients with Acute Promyelocytic Leukemia (APL) Receiving ATRA Treatment: Does It Correlate with CD2 and FLT3 Expression?.

Oral Melphalan, Prednisone and Thalidomide for Multiple Myeloma.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only